Jefferies Financial Group Inc. bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 124,316 shares of the conglomerate’s stock, valued at approximately $28,458,000.
Several other institutional investors and hedge funds have also recently modified their holdings of DHR. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter valued at about $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the fourth quarter valued at about $26,000. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter worth about $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the third quarter worth about $27,000. Finally, Financial Life Planners purchased a new stake in Danaher during the third quarter worth about $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on DHR. Evercore boosted their price target on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Barclays cut their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Wells Fargo & Company cut their price target on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research note on Friday, April 17th. Finally, Guggenheim cut their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $238.65.
Danaher Stock Performance
Shares of Danaher stock opened at $172.12 on Friday. The firm has a market capitalization of $121.82 billion, a P/E ratio of 33.29, a P/E/G ratio of 2.30 and a beta of 0.81. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm’s 50 day moving average is $183.52 and its two-hundred day moving average is $208.73.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.88 earnings per share. Research analysts forecast that Danaher Corporation will post 8.43 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
